- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Clinical markers of immunotherapy outcomes in advanced sarcoma ; volume:23 ; number:1 ; day:7 ; month:4 ; year:2023 ; pages:1-8 ; date:12.2023
BMC cancer ; 23, Heft 1 (7.4.2023), 1-8, 12.2023
- Urheber
-
Husain, Marium
Quiroga, Dionisia
Kim, Han Gil
Lenobel, Scott
Xu, Menglin
Iwenofu, Hans
Chen, James L.
Verschraegen, Claire
Liebner, David
Tinoco, Gabriel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10758-w
- URN
-
urn:nbn:de:101:1-2023082021024566916875
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Husain, Marium
- Quiroga, Dionisia
- Kim, Han Gil
- Lenobel, Scott
- Xu, Menglin
- Iwenofu, Hans
- Chen, James L.
- Verschraegen, Claire
- Liebner, David
- Tinoco, Gabriel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cellular immunotherapy in patients with advanced Ewing sarcoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously
Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancer
High cumulative doxorubicin dose for advanced soft tissue sarcoma
RNA-sequencing-based risk stratification and individualized immunotherapy strategies for soft tissue sarcoma
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma
Cellular immunotherapy in patients with advanced Ewing sarcoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously
Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancer
High cumulative doxorubicin dose for advanced soft tissue sarcoma
RNA-sequencing-based risk stratification and individualized immunotherapy strategies for soft tissue sarcoma
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma
Cellular immunotherapy in patients with advanced Ewing sarcoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously
Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancer
High cumulative doxorubicin dose for advanced soft tissue sarcoma
RNA-sequencing-based risk stratification and individualized immunotherapy strategies for soft tissue sarcoma
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma